Neurology Articles

Neurology

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mathew NT et al. – OnabotulinumtoxinA and topiramate demonstrated similar efficacy in the prophylactic treatment of chronic migraine (CM). Patients receiving onabotulinumtoxinA had fewer AEs and discontinuations.

Related Articles

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09    Relevance Score: 94%

Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09    Relevance Score: 89%

Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association
Women's Health, 10/30/09    Relevance Score: 81%

Urinary 6-Sulphatoxymelatonin Levels Are Depressed in Chronic Migraine and Several Comorbidities
Headache: The Journal of Head and Face Pain, 10/12/09    Relevance Score: 81%

Clinical management of motility disorders in children
Seminars in Pediatric Surgery, 10/01/09    Relevance Score: 81%

Today in Pain Medicine...keeping you current

Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09

Complex regional pain syndrome – Mechanisms, diagnosis, and management
Current Anaesthesia and Critical Care, 11/24/09

Novel targets in pain research: The case for CB2 receptors as a biorational pain target
Current Anaesthesia and Critical Care, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address